Triptorelin
FDA ApprovedGnRH receptor agonist / synthetic decapeptide
Triptorelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist that has been studied in reproductive endocrinology research. It has been investigated for its effects on pituitary gonadotropin release and its role in hypothalamic-pituitary-gonadal axis regulation. Published research has examined its receptor binding and pharmacological profile. RaysunPeptide supplies Triptorelin for qualified research and laboratory applications.
Mechanism of Action
Activates GnRH receptors in the pituitary. Continuous stimulation initially increases LH and FSH secretion, followed by receptor desensitization and suppression of gonadal steroidogenesis.
Key Benefits
Molecular Data
Research Indications
Oncology
Continuous GnRH receptor activation ultimately suppresses testosterone production and is used in androgen-deprivation therapy.
Endocrinology
Continuous treatment suppresses LH and FSH secretion and downstream gonadal steroidogenesis.
Reproductive Medicine
Used in selected reproductive protocols where controlled suppression of the hypothalamic-pituitary-gonadal axis is required.
What to Expect
Side Effects & Safety
Common (Generally Mild)
- •Hot flashes
- •Headache
- •Injection-site reactions
- •Mood changes
- •Hormonal symptoms
Stop Signs (Seek Medical Attention)
- ⚠Severe allergic reaction
- ⚠Severe cardiovascular symptoms
- ⚠Severe neurologic symptoms
- ⚠Severe treatment-related complications
Contraindications
- ✕Pregnancy
- ✕Hypersensitivity to triptorelin or formulation components
- ✕Product-specific contraindications
FAQs
What is triptorelin?
Triptorelin is a synthetic decapeptide analog of GnRH that acts as a potent GnRH receptor agonist.
Why does continuous triptorelin suppress hormones?
Continuous receptor stimulation produces pituitary GnRH-receptor desensitization, ultimately reducing LH and FSH secretion and gonadal steroidogenesis.
